The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy
Open accessAbstract
The American Society for Transplantation and Cellular Therapy (ASTCT) published its first white paper on indications for autologous and allogeneic hematopoietic cell transplantation (HCT) in 2015. It was identified at the time that periodic updates of indications would be required to stay abreast with state of the art and emerging indications and therapy. In recent years, the field has not only seen an improvement in transplantation technology thus widening the therapeutic scope of HCT, but additionally a whole new treatment strategy using modified immune effector cells including chimeric antigen receptor T-cell (CART-cell) and T-cell receptors (TCRs) has emerged. The guidelines review committee of the ASTCT deemed it optimal to update the ASTCT recommendations for indications for HCT to include new data and to incorporate indications for immune effector cell therapy (IECT) where appropriate. The guidelines committee established multi-stakeholder task force consisting of transplant experts, payer representatives and a patient advocate to provide guidance on indications for HCT and IECT. This manuscript presents the updated recommendations from the ASTCT on indications for HCT and IECT. Indications for HCT/IECT were categorized as (1) Standard of care, where indication is well defined and supported by evidence, (2) Standard of care, clinical evidence available, where large clinical trials and observational studies are not available but has been shown to be effective therapy, (3) Standard of care, rare indication, for rare diseases where demonstrated effectiveness exist but large clinical trials and observational studies are not feasible, (4) Developmental, for diseases where pre-clinical and/or early phase clinical studies show HCT/IECT to be a promising treatment option, and (5) Not generally recommended, where available evidence does not support the routine use of HCT/IECT. The ASTCT will continue to periodically review these guidelines and update them as new evidence becomes available.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The National Comprehensive Cancer Network: Present and future directions
McGivney, W. T. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980515)82:10+<2057::aid-cncr14>3.0.co;2-a · Cited by 16,766
Arber, D. A., Orazi, A., Hasserjian, R., Thiele, J., Borowitz, M. J., Le Beau, M. M., Bloomfield, C. D., Cazzola, M., & Vardiman, J. W. (2016) · Blood · doi:10.1182/blood-2016-03-643544 · Cited by 10,119
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
Neelapu, S. S., Locke, F. L., Bartlett, N. L., Lekakis, L. J., Miklos, D. B., Jacobson, C. A., Braunschweig, I., Oluwole, O. O., Siddiqi, T., Lin, Y., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707447 · Cited by 6,030
Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia
Maude, S. L., Laetsch, T. W., Buechner, J., Rives, S., Boyer, M., Bittencourt, H., Bader, P., Verneris, M. R., Stefanski, H. E., Myers, G. D., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1709866 · Cited by 5,735
Chimeric Antigen Receptor Therapy
June, C. H., & Sadelain, M. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1706169 · Cited by 2,331
Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas
Schuster, S. J., Svoboda, J., Chong, E. A., Nasta, S. D., Mato, A. R., Anak, Ö., Brogdon, J. L., Pruteanu-Malinici, I., Bhoj, V., Landsburg, D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1708566 · Cited by 1,860
Anti-BCMA CAR T-cell therapy bb2121 in relapsed or refractory multiple myeloma.
Raje, N., Berdeja, J., Lin, Y., Siegel, D., Jagannath, S., Madduri, D., Liedtke, M., Rosenblatt, J., Maus, M. V., Turka, A., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1817226 · Cited by 1,730
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
Gooley, T. A., Chien, J. W., Pergam, S. A., Hingorani, S., Sorror, M. L., Boeckh, M., Martin, P. J., Sandmaier, B. M., Marr, K. A., Appelbaum, F. R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1004383 · Cited by 1,493
Rocha, V., Labopin, M., Sanz, G., Arcese, W., Schwerdtfeger, R., Bosi, A., Jacobsen, N., Ruutu, T., de Lima, M., Finke, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041469 · Cited by 1,101
Laughlin, M. J., Eapen, M., Rubinstein, P., Wagner, J. E., Zhang, M.-J., Champlin, R. E., Stevens, C., Barker, J. N., Gale, R. P., Lazarus, H. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041276 · Cited by 1,062
Self-citationEapen, M., Rubinstein, P., Zhang, M.-J., Stevens, C., Kurtzberg, J., Scaradavou, A., Loberiza, F. R., Champlin, R. E., Klein, J. P., Horowitz, M. M., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60915-5 · Cited by 799
Self-citationCiurea, S. O., Zhang, M.-J., Bacigalupo, A. A., Bashey, A., Appelbaum, F. R., Aljitawi, O. S., Armand, P., Antin, J. H., Chen, J., Devine, S. M., et al. (2015) · Blood · doi:10.1182/blood-2015-04-639831 · Cited by 662
Self-citationMyeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma
Sullivan, K. M., Goldmuntz, E. A., Keyes-Elstein, L., McSweeney, P. A., Pinckney, A., Welch, B., Mayes, M. D., Nash, R. A., Crofford, L. J., Eggleston, B., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1703327 · Cited by 603
Self-citationBurt, R. K., Shah, S. J., Dill, K., Grant, T., Gheorghiade, M., Schroeder, J., Craig, R., Hirano, I., Marshall, K., Ruderman, E., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60982-3 · Cited by 578
Wang, Y., Liu, Q.-F., Xu, L.-P., Liu, K.-Y., Zhang, X.-H., Ma, X., Fan, Z.-P., Wu, D.-P., & Huang, X.-J. (2015) · Blood · doi:10.1182/blood-2015-02-627786 · Cited by 486
de Witte, T., Bowen, D., Robin, M., Malcovati, L., Niederwieser, D., Yakoub-Agha, I., Mufti, G. J., Fenaux, P., Sanz, G., Martino, R., et al. (2017) · Blood · doi:10.1182/blood-2016-06-724500 · Cited by 379
Self-citationInternational Working Group consensus response evaluation criteria in lymphoma (RECIL 2017)
Younes, A., Hilden, P., Coiffier, B., Hagenbeek, A., Salles, G., Wilson, W., Seymour, J. F., Kelly, K., Gribben, J., Pfreunschuh, M., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx097 · Cited by 369
Park, J. R., Kreissman, S. G., London, W. B., Naranjo, A., Cohn, S. L., Hogarty, M. D., Tenney, S. C., Haas-Kogan, D., Shaw, P. J., Kraveka, J. M., et al. (2019) · JAMA · doi:10.1001/jama.2019.11642 · Cited by 358
Atkins, H. L., Bowman, M., Allan, D., Anstee, G., Arnold, D. L., Bar-Or, A., Bence-Bruckler, I., Birch, P., Bredeson, C., Chen, J., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30169-6 · Cited by 325
Self-citationBurt, R. K., Balabanov, R., Burman, J., Sharrack, B., Snowden, J. A., Oliveira, M. C., Fagius, J., Rose, J., Nelson, F., Barreira, A. A., et al. (2019) · JAMA · doi:10.1001/jama.2018.18743 · Cited by 313
Muffly, L., Pasquini, M. C., Martens, M., Brazauskas, R., Zhu, X., Adekola, K., Aljurf, M., Ballen, K. K., Bajel, A., Baron, F., et al. (2017) · Blood · doi:10.1182/blood-2017-03-772368 · Cited by 297
Self-citationMcDonald, G. B., Sandmaier, B. M., Mielcarek, M., Sorror, M., Pergam, S. A., Cheng, G.-S., Hingorani, S., Boeckh, M., Flowers, M. D., Lee, S. J., et al. (2020) · Annals of Internal Medicine · doi:10.7326/m19-2936 · Cited by 285
Raiola, A. M., Dominietto, A., di Grazia, C., Lamparelli, T., Gualandi, F., Ibatici, A., Bregante, S., Van Lint, M. T., Varaldo, R., Ghiso, A., et al. (2014) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2014.05.029 · Cited by 283
Saber, W., Opie, S., Rizzo, J. D., Zhang, M.-J., Horowitz, M. M., & Schriber, J. (2012) · Blood · doi:10.1182/blood-2011-09-381699 · Cited by 250
Self-citationAutologous hematopoietic stem cell transplantation in multiple sclerosis: A phase II trial
Mancardi, G. L., Sormani, M. P., Gualandi, F., Saiz, A., Carreras, E., Merelli, E., Donelli, A., Lugaresi, A., Di Bartolomeo, P., Rottoli, M. R., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001329 · Cited by 249
CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia
Pan, J., Niu, Q., Deng, B., Liu, S., Wu, T., Gao, Z., Liu, Z., Zhang, Y., Qu, X., Zhang, Y., et al. (2019) · Leukemia · doi:10.1038/s41375-019-0488-7 · Cited by 243
Jain, T., Bar, M., Kansagra, A. J., Chong, E. A., Hashmi, S. K., Neelapu, S. S., Byrne, M., Jacoby, E., Lazaryan, A., Jacobson, C. A., et al. (2019) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2019.08.015 · Cited by 191
Self-citationHematopoietic Stem-Cell Transplantation for Advanced Systemic Mastocytosis
Ustun, C., Reiter, A., Scott, B. L., Nakamura, R., Damaj, G., Kreil, S., Shanley, R., Hogan, W. J., Perales, M.-A., Shore, T., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.2018 · Cited by 190
Self-citationRoos-Weil, D., Dietrich, S., Boumendil, A., Polge, E., Bron, D., Carreras, E., Iriondo Atienza, A., Arcese, W., Beelen, D. W., Cornelissen, J. J., et al. (2013) · Blood · doi:10.1182/blood-2012-08-448613 · Cited by 177
Autologous hematopoietic stem cell transplantation in multiple sclerosis: A meta-analysis
Sormani, M. P., Muraro, P. A., Schiavetti, I., Signori, A., Laroni, A., Saccardi, R., & Mancardi, G. L. (2017) · Neurology · doi:10.1212/wnl.0000000000003987 · Cited by 167
Kharfan‐Dabaja, M. A., Kumar, A., Ayala, E., Hamadani, M., Reimer, P., Gisselbrecht, C., d’Amore, F., Jantunen, E., Ishida, T., Bazarbachi, A. A., et al. (2017) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2017.07.027 · Cited by 158
Self-citationOliansky, D. M., Appelbaum, F., Cassileth, P. A., Keating, A., Kerr, J., Nieto, Y., Stewart, S., Stone, R. M., Tallman, M. S., McCarthy, P. L., et al. (2008) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2007.11.002 · Cited by 158
Shah, N., Callander, N. S., Ganguly, S., Gul, Z., Hamadani, M., Costa, L. J., Sengsayadeth, S. M., Abidi, M. H., Hari, P., Mohty, M., et al. (2015) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2015.03.002 · Cited by 128
Self-citationOliansky, D. M., Camitta, B. M., Gaynon, P. S., Nieder, M. L., Parsons, S. K., Pulsipher, M. A., Dillon, H., Ratko, T. A., Wall, D. A., McCarthy, P. L., et al. (2011) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2011.12.585 · Cited by 120
Dreger, P., Sureda, A. M., Ahn, K. W., Eapen, M., Litovich, C., Finel, H., Boumendil, A., Gopal, A. K., Herrera, A. F., Schmid, C., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2018027748 · Cited by 115
Self-citationMcCarthy, P. L., Hahn, T., Hassebroek, A. M., Bredeson, C., Gajewski, J., Hale, G. A., Isola, L. M., Lazarus, H. M., Lee, S. J., LeMaistre, C. F., et al. (2013) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2013.04.027 · Cited by 113
Self-citationKharfan‐Dabaja, M. A., Kumar, A., Hamadani, M., Stilgenbauer, S., Ghia, P., Anasetti, C., Dreger, P., Montserrat, E., Perales, M., Alyea, E. P., et al. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.09.013 · Cited by 111
Self-citationKansagra, A. J., Frey, N. V., Bar, M., Laetsch, T. W., Carpenter, P. A., Savani, B. N., Heslop, H. E., Bollard, C. M., Komanduri, K. V., Gastineau, D. A., et al. (2018) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2018.12.068 · Cited by 110
Self-citationCohen, J. A., Baldassari, L. E., Atkins, H. L., Bowen, J. D., Bredeson, C., Carpenter, P. A., Corboy, J. R., Freedman, M. S., Griffith, L. M., Lowsky, R., et al. (2019) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2019.02.014 · Cited by 108
Self-citationSaber, W., Cutler, C. S., Nakamura, R., Zhang, M., Atallah, E. L., Rizzo, J. D., Maziarz, R. T., Cortes, J. E., Kalaycio, M. E., & Horowitz, M. M. (2013) · Blood · doi:10.1182/blood-2013-04-496778 · Cited by 104
Self-citationConsensus Opinion on Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis
Üstün, C., Gotlib, J. R., Popat, U., Artz, A. S., Litzow, M. R., Reiter, A., Nakamura, R., Kluin‐Nelemans, H. C., Verstovšek, S., Gajewski, J., et al. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.04.018 · Cited by 104
Self-citation(IWP), O. B. O. T. E. A. D. W. P. (. A. I. W. P., Alexander, T., Bondanza, A., Muraro, P. A., Greco, R., Saccardi, R., Daikeler, T. D., Kazmi, M., Hawkey, C. J., Simões, B. P., et al. (2014) · Bone Marrow Transplantation · doi:10.1038/bmt.2014.251 · Cited by 94
Kharfan‐Dabaja, M. A., Malki, M. M. A., Deotare, U. R., Raj, R. V., El‐Jurdi, N., Majhail, N. S., Cherry, M. A., Bashir, Q., Darrah, J. M., Nishihori, T., et al. (2017) · British Journal of Haematology · doi:10.1111/bjh.14954 · Cited by 87
Self-citationde Latour, R. P., Brunstein, C. G., Porcher, R., Chevallier, P., Robin, M., Warlick, E. D., Xhaard, A., Üstün, C., Larghero, J., Dhédin, N., et al. (2013) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2013.06.006 · Cited by 86
Oliansky, D. M., Antin, J. H., Bennett, J. M., Deeg, H. J., Engelhardt, C., Heptinstall, K. V., Lima, M. J. G. D., Gore, S. D., Potts, R. G., Silverman, L. R., et al. (2009) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2008.12.003 · Cited by 84
Smith, S. M., Godfrey, J. K., Ahn, K. W., Digilio, A., Ahmed, S., Agrawal, V., Bachanová, V., Bacher, U., Bashey, A., Bolaños‐Meade, J., et al. (2018) · Cancer · doi:10.1002/cncr.31374 · Cited by 79
Self-citationWildes, T. M., Stirewalt, D. L., Medeiros, B. C., & Hurria, A. (2014) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2014.0010 · Cited by 62
Zhang, M., Davies, S. M., Camitta, B. M., Logan, B. R., Tiedemann, K., & Eapen, M. (2012) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2012.01.007 · Cited by 59
Hashmi, S. K., Lee, S. J., Savani, B. N., Burns, L. J., Wingard, J. R., Perales, M., Palmer, J. M., Chow, E. J., Meyer, E. H., Marks, D. I., et al. (2018) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2018.03.023 · Cited by 54
Self-citationAllogeneic stem cell transplantation for sickle cell disease
Robinson, T. M., & Fuchs, E. J. (2016) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000282 · Cited by 35
Hematopoietic stem cell transplantation in older persons: respecting the heterogeneity of age
Michaelis, L. C., Hamadani, M., & Hari, P. (2014) · Expert Review of Hematology · doi:10.1586/17474086.2014.913978 · Cited by 10
Self-citation
Cited by
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States
D'Souza, A., Fretham, C., Lee, S. J., Arora, M., Brunner, J., Chhabra, S., Devine, S., Eapen, M., Hamadani, M., Hari, P., et al. (2020) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2020.04.013 · Cited by 712
Self-citation
Metadata
- Authors
- Kanate, A. S., Majhail, N. S., Savani, B. N., Bredeson, C., Champlin, R. E., Crawford, S., Giralt, S. A., LeMaistre, C. F., Marks, D. I., Omel, J. L., Orchard, P. J., Palmer, J., Saber, W., Veys, P. A., Carpenter, P. A., & Hamadani, M.
- Venue
- Biology of Blood and Marrow Transplantation
- Publisher
- Elsevier BV
- Published
- 2020-07
- Volume
- 26
- Issue
- 7
- Pages
- 1247-1256
- ISSN
- 1083-8791 (ISSN-L)
- OpenAlex
- W3010357077
- Cited by
- 283
- References
- 51
- FWCI
- 19.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.